PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice

被引:34
作者
Brown, Jacquelyn A. [1 ]
Xu, Jinbin [2 ]
Diggs-Andrews, Kelly A. [1 ]
Wozniak, David F. [3 ]
Mach, Robert H. [2 ]
Gutmann, David H. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
关键词
Dopamine; Behavior; Neurofibromin; Cyclic AMP; RAS; SELECTIVE RADIOLIGAND; DOPAMINE D-3; MOUSE MODEL; TYPE-1; BRAIN; METHYLPHENIDATE; HETEROZYGOSITY; UNDERLIES; DISORDER; CHILDREN;
D O I
10.1016/j.expneurol.2011.09.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Attention system abnormalities represent a significant barrier to scholastic achievement in children with neurofibromatosis-1 (NF1). Using a novel mouse model of NF1-associated attention deficit (ADD), we demonstrate a presynaptic defect in striatal dopaminergic homeostasis and leverage this finding to apply [(11)C]-raclopride positron-emission tomography (PET) in the intact animal. While methylphenidate and L-Deprenyl correct both striatal dopamine levels on PET imaging and defective attention system function in Nf1 mutant mice, pharmacologic agents that target de-regulated cyclic AMP and RAS signaling in these mice do not. These studies establish a robust preclinical model to evaluate promising agents for NF1-associated ADD. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 24 条
[11]   Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1 - A randomized controlled trial [J].
Krab, Lianne C. ;
de Goede-Bolder, Arja ;
Aarsen, Femke K. ;
Pluijm, Saskia M. F. ;
Bouman, Marlies J. ;
van der Geest, Jos N. ;
Lequin, Maarten ;
Catsman, Coriene E. ;
Arts, Willem Frans M. ;
Kushner, Steven A. ;
Silva, Alcino J. ;
de Zeeuw, Chris I. ;
Moll, Henriette A. ;
Elgersma, Ype .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (03) :287-294
[12]   The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1 [J].
Li, WD ;
Cui, YJ ;
Kushner, SA ;
Brown, RAM ;
Jentsch, JD ;
Frankland, PW ;
Cannon, TD ;
Silva, AJ .
CURRENT BIOLOGY, 2005, 15 (21) :1961-1967
[13]   Graphical analysis of PET data applied to reversible and irreversible tracers [J].
Logan, J .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (07) :661-670
[14]   Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder [J].
Rosa-Neto, P ;
Lou, HC ;
Cumming, P ;
Pryds, O ;
Karrebaek, H ;
Lunding, J ;
Gjedde, A .
NEUROIMAGE, 2005, 25 (03) :868-876
[15]   AUTORADIOGRAPHIC LOCALIZATION OF D1 DOPAMINE-RECEPTORS IN THE RAT-BRAIN WITH [H-3] SCH-23390 [J].
SAVASTA, M ;
DUBOIS, A ;
SCATTON, B .
BRAIN RESEARCH, 1986, 375 (02) :291-301
[16]   Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine [J].
Schiffer, WK ;
Volkow, ND ;
Fowler, JS ;
Alexoff, DL ;
Logan, J ;
Dewey, SL .
SYNAPSE, 2006, 59 (04) :243-251
[17]  
Thanos PK, 2002, J NUCL MED, V43, P1570
[18]   Neurofibromin regulates G protein-stimulated adenylyl cyclase activity [J].
Tong, JY ;
Hannan, F ;
Zhu, YH ;
Bernards, A ;
Zhong, Y .
NATURE NEUROSCIENCE, 2002, 5 (02) :95-96
[19]   Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice [J].
Vallone, D ;
Pignatelli, M ;
Grammatikopoulos, G ;
Ruocco, L ;
Bozzi, Y ;
Westphal, H ;
Borrelli, E ;
Sadile, AG .
BEHAVIOURAL BRAIN RESEARCH, 2002, 130 (1-2) :141-148
[20]   Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder [J].
Volkow, Nora D. ;
Wang, Gene-Jack ;
Newcorn, Jeffrey ;
Telang, Frank ;
Solanto, Mary V. ;
Fowler, Joanna S. ;
Logan, Jean ;
Ma, Yeming ;
Schulz, Kurt ;
Pradhan, Kith ;
Wong, Christopher ;
Swanson, James M. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (08) :932-940